OT
Overture develops precision antibody therapeutics engineered to treat obesity by targeting the root drivers of metabolic dysfunction. Their platform focuses on creating highly targeted treatments that reduce fat mass while preserving lean muscle tissue. These next-generation therapies leverage well-validated biological pathways for improved patient outcomes.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Overture develops precision antibody therapeutics engineered for next-generation obesity treatments. Their approach targets the root drivers of metabolic dysfunction to reduce fat mass while preserving lean muscle tissue. These modular therapies utilize well-validated biological pathways for highly targeted patient subgroup treatment.